MetLife Investment Management, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$504,451
-54.7%
43,9800.0%0.00%
-50.0%
Q2 2023$1,113,134
-18.4%
43,980
+3.9%
0.01%
-20.0%
Q1 2023$1,363,353
+74.5%
42,3270.0%0.01%
+66.7%
Q4 2022$781,356
-26.0%
42,327
+8.2%
0.01%
-33.3%
Q3 2022$1,056,429
+95.4%
39,1270.0%0.01%
+125.0%
Q2 2022$540,735
-29.1%
39,1270.0%0.00%
-20.0%
Q1 2022$762,977
+83.8%
39,127
+53.8%
0.01%
+25.0%
Q4 2021$415,067
-41.4%
25,4330.0%0.00%
-42.9%
Q3 2021$708,563
-6.0%
25,4330.0%0.01%0.0%
Q2 2021$753,834
+6.0%
25,4330.0%0.01%0.0%
Q1 2021$710,852
-1.4%
25,4330.0%0.01%0.0%
Q4 2020$720,771
+12.7%
25,4330.0%0.01%0.0%
Q3 2020$639,386
+2.9%
25,4330.0%0.01%0.0%
Q2 2020$621,074
+96.6%
25,433
+19.1%
0.01%
+75.0%
Q1 2020$315,950
-8.8%
21,3480.0%0.00%0.0%
Q4 2019$346,478
+24.8%
21,3480.0%0.00%
+33.3%
Q3 2019$277,524
+0.2%
21,3480.0%0.00%0.0%
Q2 2019$276,882
+13.1%
21,348
+37.4%
0.00%0.0%
Q1 2019$244,784
-21.7%
15,5320.0%0.00%
-25.0%
Q4 2018$312,659
-19.0%
15,5320.0%0.00%0.0%
Q3 2018$385,970
-9.4%
15,5320.0%0.00%
-20.0%
Q2 2018$426,000
+26.0%
15,532
+41.5%
0.01%
+25.0%
Q1 2018$338,000
-13.8%
10,9750.0%0.00%0.0%
Q4 2017$392,00010,9750.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders